Related Experiment Video
Updated: Jun 7, 2026

Induction and Validation of Cellular Senescence in Primary Human Cells
Published on: June 20, 2018
[Senescence and cellular immortality]
1Structure des acides nucléiques, télomères et évolution, Muséum national d'histoire naturelle, Inserm U565, CNRS UMR 7196, 75005 Paris, France.
Abstract:
Senescence was originally described from the observation of the limited ability of normal cells to grow in culture, and may be generated by telomere erosion, accumulation of DNA damages, oxidative stress and modulation of oncogenes or tumor suppressor genes. Senescence corresponds to a cellular response aiming to control tumor progression by limiting cell proliferation and thus constitutes an anticancer barrier. Senescence is observed in pre-malignant tumor stages and disappears from malignant tumors. Agents used in standard chemotherapy also have the potential to induce senescence, which may partly explain their therapeutic activities. It is possible to restore senescence in tumors using targeted therapies that triggers telomere dysfunction or reactivates suppressor genes functions, which are essential for the onset of senescence.
Insights
Cellular senescence, a state of limited cell growth, acts as an anticancer barrier by preventing tumor progression. Therapies can potentially restore senescence in tumors, offering a new anticancer strategy.
Area of Science:
- Cellular biology
- Oncology
- Molecular genetics
Background:
- Cellular senescence is characterized by limited cell proliferation.
- Senescence can be triggered by telomere erosion, DNA damage, oxidative stress, and oncogene/tumor suppressor gene modulation.
- Senescence functions as an anticancer mechanism, observed in pre-malignant stages but absent in malignant tumors.
Purpose of the Study:
- To explore the role of cellular senescence as an anticancer barrier.
- To investigate the potential of inducing senescence as a therapeutic strategy against cancer.
Main Methods:
- Review of existing literature on cellular senescence.
- Analysis of the mechanisms triggering senescence.
- Examination of the role of senescence in tumor progression and chemotherapy.
Main Results:
- Senescence limits cell proliferation, acting as a barrier against tumor development.
- Standard chemotherapy agents can induce senescence, contributing to their therapeutic effects.
- Malignant tumors often lose senescence, indicating its suppressive role.
Conclusions:
- Cellular senescence is a crucial anticancer mechanism.
- Targeted therapies can potentially restore senescence in tumors by inducing telomere dysfunction or reactivating suppressor genes.
- Restoring senescence presents a promising avenue for cancer treatment.
Related Concept Videos
Replicative Cell Senescence
Replicative Cell Senescence
Telomeres and Telomerase
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
The Effect of Aging on Tissues
Mitochondria

